Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Sympathetic Overactivity in Essential Hypertension

This study has been withdrawn prior to enrollment.
(No patients could be recruited.)
Sponsor:
Information provided by (Responsible Party):
University of Erlangen-Nürnberg Medical School
ClinicalTrials.gov Identifier:
NCT00541619
First received: October 9, 2007
Last updated: April 16, 2013
Last verified: April 2013

October 9, 2007
April 16, 2013
October 2007
March 2011   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00541619 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Sympathetic Overactivity in Essential Hypertension
Sympathetic Overactivity in Essential Hypertension

The primary objective of the study is whether subjects with hypertension and proteinuria display increased sympathetic nerve activity compared to hypertensive subjects without proteinuria and normotensive controls.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

Patients with primary hypertension.

  • Hypertension
  • Proteinuria
Not Provided
A
hypertensives with proteinuria
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Withdrawn
0
March 2011
March 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Normotension or hypertension

Exclusion Criteria:

  • Pregnant and nursing women
  • Myocardial infarction, clinical signs of coronary heart disease
  • Severe depression
Both
18 Years to 70 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT00541619
RE-No.3210
Not Provided
University of Erlangen-Nürnberg Medical School
University of Erlangen-Nürnberg Medical School
Not Provided
Principal Investigator: Roland Veelken, MD principal investigator
University of Erlangen-Nürnberg Medical School
April 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP